We turn scattered oncology papers, news, and trials into clear, connected guidance — across every major brain and spine tumor type.
For patients, caregivers & clinicians · Free forever
Each portal is a dedicated intelligence hub — guides, trials, publications, and a clear brief, built for one community. Choose the tumor type you’re here for.
Astrocytomas, oligodendrogliomas & glioblastoma.
Tumors of the meninges, most often benign.
Embryonal tumors, most common in children.
Tumors arising from ependymal cells.
Nerve-sheath tumors, incl. acoustic neuroma.
Adenomas affecting hormones & vision.
Intramedullary & extramedullary lesions.
Secondary tumors spread from other cancers.
Lymphoma confined to the brain & spine.
Zyntha tracks papers, news, trials, guidelines, and recurring themes — then turns them into patient-readable intelligence: what changed, why it matters, what connects to prior evidence, and what to watch next.
We read thousands of global medical sources around the clock, analyse new studies as they emerge, and organise everything by clinical significance.
Continuously scanning ClinicalTrials.gov, PubMed, the FDA and thousands of sources across nine tumor types.
Every study is classified by tumor type, scored for relevance, and enriched with molecular markers and treatment data.
Browse specialised portals, explore active trials, or read curated intelligence — all in clear, everyday language.
This platform was built after a personal diagnosis made one thing obvious: breakthroughs are happening everywhere, but reliable answers are scattered across journals, databases, and institutions.
We believe people facing cancer deserve something better. So we built Zyntha.
All content comes from peer-reviewed journals, verified trial registries, and top cancer research centres.
Every article is scored for relevance, classified by tumor type, and summarised in patient-friendly language before it reaches you.
We are not medical professionals. This platform is for educational and research purposes only — always consult your healthcare team for treatment decisions.
